SLU-PP-332 is a small-molecule agonist of estrogen-related receptors alpha and gamma (ERRα/ERRγ), developed at Saint Louis University. Research investigations have focused on its ability to activate transcriptional programs associated with oxidative metabolism, mitochondrial biogenesis, and fatty acid oxidation in skeletal muscle tissue.
In preclinical research settings, SLU-PP-332 has been studied for its exercise-mimetic properties. Published investigations have examined its effects on endurance capacity, metabolic gene expression, and muscle fiber-type composition in animal models. Studies have explored its mechanism of action through ERR-mediated transcriptional activation of genes involved in mitochondrial function and energy metabolism, positioning it as a research tool for studying exercise physiology pathways.
Supplied as a lyophilized powder for reconstitution. Intended for research purposes only.
